Update on ocular cicatricial pemphigoid and emerging treatments
- PMID: 26708362
- DOI: 10.1016/j.survophthal.2015.12.007
Update on ocular cicatricial pemphigoid and emerging treatments
Abstract
Mucous membrane pemphigoid is a systemic disorder that primarily affects mucous membranes. When localized to the conjunctiva, it is known as ocular cicatricial pemphigoid, a potentially blinding disease. Ocular cicatricial pemphigoid is an indication for systemic immunosuppressive treatment to achieve adequate remission. Immunosuppressive agents are selected with a "stepladder" approach, commencing with medications having the fewest side effects. We provide an update of the literature on immunomodulatory agents since 2011 as additional treatment modalities have been explored in the last 4 years.
Keywords: alkylating agents; biologic agents; chemotherapy; immunomodulatory therapy; mucus membrane pemphigoid; ocular cicatricial pemphigoid.
Copyright © 2016 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
